GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
NewLink Genetics Corp (NLNK) [hlAlert]

NewLink Genetics Corporation (NewLink) is a development-stage company. The Company is a biopharmaceutical company focused on discovering, developing and commercializing immunotherapeutic products for cancer treatment. Its portfolio includes biologic and small-molecule immunotherapy product candidates focused to
treat a range of oncology indications. Its product candidate, HyperAcute Pancreas cancer immunotherapy (HyperAcute Pancreas), is being studied in a Phase-III clinical trial in surgically-resected pancreatic cancer patients that is being performed under a Special Protocol Assessment (SPA), with the United States Food and Drug Administration (FDA). It has three additional product candidates in clinical development, including its HyperAcute Lung cancer immunotherapy (HyperAcute Lung) and its HyperAcute Melanoma cancer immunotherapy (HyperAcute Melanoma).
( Total: 8 Current Stock Recommendations )
NewLink Genetics Corp   (8)
Hold Buy 88%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
12/21/2011  
Buy
  
5/28/2012  
Buy
  
5/29/2013  
Buy
  
6/14/2013  
Buy
  
3/3/2014  
Hold
  
3/31/2014  
Buy
  
9/12/2014  
Buy
  
11/7/2014  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy